Augmenting effect of antibiotics on endotoxin activity may cause a safety problem.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001773:Blood Cells / Q000187:drug effects*; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D004340:Drug Contamination / Q000517:prevention & control; D004357:Drug Synergism; D004731:Endotoxins / Q000633:toxicity*; D005260:Female; D005688:Galactosamine; D006801:Humans; D015850:Interleukin-6 / Q000096:biosynthesis; D007769:Lactams / Q000494:pharmacology*; D051379:Mice; D008809:Mice, Inbred C3H; D012449:Safety
D000900:Anti-Bacterial Agents; D004731:Endotoxins; D015850:Interleukin-6; D007769:Lactams; D005688:Galactosamine